Workflow Efficiency Benefits Drives the Global Digital Pathology Systems Market, According to New Report by Global Industry Analysts, Inc.

GIA announces the release of a comprehensive global report on Digital Pathology Systems markets. Global market for Digital Pathology Systems is projected to reach US$542 million by 2018, primarily driven by benefits offered in terms of improvement in workflow efficiency and reduction of operational costs.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Digital Pathology Systems: A Global Strategic Business Report

San Jose, California (PRWEB) April 02, 2013

Follow us on LinkedIn – Digital Pathology, a new cutting edge technology for use by laboratory professionals and pathologists, promises to overcome limitations posed by traditional workflow processes, offering long-term cost and efficiency related outcomes. Digital pathology systems offer a digital environment for capturing, storing, managing, and interpreting pathological data and images. These systems are gaining attention from pathology laboratories worldwide. The technology is finding increased application in end-use sectors like research, education and diagnostics. Key benefits offered by the technology include enhanced workflow efficiency, reduced costs of operating pathological processes, quicker acquisition of high resolution images, faster and accurate diagnosis, and compliance with regulatory standards with respect to information management. Other external factors driving growth in the market include need for improving efficiency in drug development, emergence of companion diagnostics and benefits offered in the field of cancer diagnosis.

Until recently, use of digital pathology systems was limited to niche research applications. The technology currently finds applications in numerous end-use markets. Clinical research especially is forecast to witness strong demand for digital pathology systems. Image-based technologies play an important role in managing and interpreting information generated from digital slides. Digital pathology also assumes importance as a tool to enhance the drug development process, especially during pre-clinical trials. The technology enables users to run morphology algorithms and quantitative immunohistochemistry on virtual digitized slides and provides assistance in organizing and annotating these slides to enhance productivity.

Digitization of healthcare services has resulted in outsourcing of various medical services, including diagnostic and clinical services. The continuing push towards digitization as part of healthcare reforms implemented by governments worldwide to reduce costs is expected to fuel growth in the market. The coming years will witness the concept of telepathology outsourcing migrating from developed nations to countries such as India and China. Cloud computing is rapidly making inroads into the digital pathology space in the form of cloud hosting, digital pathology as a service, and web-applications. Cloud hosted digital pathology services eliminate the need for upfront capital investment and make the technology affordable by even smaller pathology labs thus supporting technology penetration across all tiers of the market. In a bid to capitalize on the opportunities offered, vendors are now focusing on developing new models for providing cloud storage services that allow users to reduce costs and effectively address pathology related data storage and connectivity issues.

Despite the growth potential in the offing, digital pathology faces numerous technology challenges, characteristic of all evolving technologies. Challenges that threaten to impede widespread market adoption include high implementation costs, technical bottlenecks related to pathology workflow, data storage and interoperability issues and complexities involved in integrating digital pathology with Laboratory Information Systems (LIS).

As stated by the new market research report on Digital Pathology Systems, the US represents the single largest market worldwide. Digital pathology product manufacturing, including scanners, software and related hardware, in the country are governed and regulated as medical devices by the USFDA. Asia-Pacific is forecast to emerge as the fastest growing market with sales projected to grow at a CAGR of 20% over the analysis period.

Major players in the market include AccelPath Inc., Apollo PACS Inc., Definiens AG, Leica Microsystems GmbH, Aperio Technologies Inc., MikroScan Technologies Inc., Olympus America Inc., Omnyx, LLC, Ventana Medical Systems Inc., among others.

The research report titled "Digital Pathology Systems: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections in US$ for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), Asia Pacific and Rest of World.

For more details about this comprehensive market research report, please visit –
http://www.strategyr.com/Digital_Pathology_Systems_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes more than 1300 full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.

Follow us on LinkedIn

Global Industry Analysts, Inc.
Telephone: 408-528-9966
Fax: 408-528-9977
Email: press(at)StrategyR(dot)com
Web Site: http://www.StrategyR.com/

###


Contact

Attachments